Annual Current Assets
$14.22 M
-$20.15 M-58.63%
September 30, 2024
Summary
- As of February 8, 2025, CTXR annual total current assets is $14.22 million, with the most recent change of -$20.15 million (-58.63%) on September 30, 2024.
- During the last 3 years, CTXR annual current assets has fallen by -$58.59 million (-80.47%).
- CTXR annual current assets is now -80.47% below its all-time high of $72.81 million, reached on September 30, 2021.
Performance
CTXR Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Current Assets
$14.22 M
-$13.79 M-49.22%
September 30, 2024
Summary
- As of February 8, 2025, CTXR quarterly total current assets is $14.22 million, with the most recent change of -$13.79 million (-49.22%) on September 30, 2024.
- Over the past year, CTXR quarterly current assets has dropped by -$13.79 million (-49.22%).
- CTXR quarterly current assets is now -87.84% below its all-time high of $116.94 million, reached on June 30, 2021.
Performance
CTXR Quarterly Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Current Assets Formula
Current Assets = Cash and Equivalents + Accounts Receivable + Inventory + Prepaid Expenses + Marketable Securities + Other Current Assets
CTXR Current Assets Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | -58.6% | -49.2% |
3 y3 years | -80.5% | -49.2% |
5 y5 years | +79.1% | -49.2% |
CTXR Current Assets Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | -80.5% | at low | -79.1% | at low |
5 y | 5-year | -80.5% | +79.1% | -87.8% | +401.5% |
alltime | all time | -80.5% | -100.0% | -87.8% | -100.0% |
Citius Pharmaceuticals Current Assets History
Date | Annual | Quarterly |
---|---|---|
Sep 2024 | $102.43 M(+47.9%) | $14.22 M(-49.2%) |
Jun 2024 | - | $28.01 M(+29.8%) |
Mar 2024 | - | $21.57 M(-23.5%) |
Dec 2023 | - | $28.21 M(-17.9%) |
Sep 2023 | $69.24 M(-0.3%) | $34.37 M(-16.4%) |
Jun 2023 | - | $41.11 M(+17.8%) |
Mar 2023 | - | $34.90 M(-17.5%) |
Dec 2022 | - | $42.32 M(-5.0%) |
Sep 2022 | - | $44.56 M(-12.3%) |
Sep 2022 | $69.44 M(-0.3%) | - |
Jun 2022 | - | $50.83 M(-12.7%) |
Mar 2022 | - | $58.26 M(-14.3%) |
Dec 2021 | - | $67.94 M(-6.7%) |
Sep 2021 | $69.61 M(+133.7%) | $72.81 M(-37.7%) |
Jun 2021 | - | $116.94 M(+11.4%) |
Mar 2021 | - | $104.97 M(+1781.6%) |
Dec 2020 | - | $5.58 M(-60.1%) |
Sep 2020 | $29.79 M(+3.4%) | $13.98 M(+63.2%) |
Jun 2020 | - | $8.57 M(+95.1%) |
Mar 2020 | - | $4.39 M(+54.9%) |
Dec 2019 | - | $2.84 M(-64.3%) |
Sep 2019 | $28.80 M(+37.2%) | $7.94 M(+74.3%) |
Jun 2019 | - | $4.56 M(+40.4%) |
Mar 2019 | - | $3.25 M(-54.2%) |
Dec 2018 | - | $7.09 M(-29.5%) |
Sep 2018 | $20.99 M | $10.06 M(+254.9%) |
Jun 2018 | - | $2.83 M(-44.1%) |
Date | Annual | Quarterly |
---|---|---|
Mar 2018 | - | $5.07 M(-32.2%) |
Dec 2017 | - | $7.48 M(+118.5%) |
Sep 2017 | $20.99 M(-0.3%) | $3.42 M(+515.3%) |
Jun 2017 | - | $556.50 K(+62.2%) |
Mar 2017 | - | $343.20 K(-30.0%) |
Dec 2016 | - | $490.30 K(-45.1%) |
Sep 2016 | $21.06 M(>+9900.0%) | $892.80 K(-55.8%) |
Jun 2016 | - | $2.02 M(-46.5%) |
Mar 2016 | - | $3.78 M(+1006.8%) |
Dec 2015 | - | $341.50 K(-53.6%) |
Sep 2015 | $5400.00(0.0%) | $736.10 K(-23.1%) |
Jun 2015 | - | $956.90 K(+25.8%) |
Mar 2015 | - | $760.40 K(-7.0%) |
Dec 2014 | - | $817.20 K(-47.3%) |
Sep 2014 | $5400.00(>+9900.0%) | $1.55 M(>+9900.0%) |
Jun 2014 | - | $0.00(0.0%) |
Mar 2014 | - | $0.00(-100.0%) |
Dec 2013 | - | $6000.00(>+9900.0%) |
Sep 2013 | $0.00(0.0%) | $0.00(0.0%) |
Jun 2013 | - | $0.00(-100.0%) |
Mar 2013 | - | $100.00(0.0%) |
Dec 2012 | - | $100.00(0.0%) |
Sep 2012 | $0.00(0.0%) | $100.00(-50.0%) |
Jun 2012 | - | $200.00(>+9900.0%) |
Mar 2012 | - | $0.00(-100.0%) |
Dec 2011 | - | $200.00(0.0%) |
Sep 2011 | $0.00 | $200.00(+100.0%) |
Jun 2011 | - | $100.00 |
FAQ
- What is Citius Pharmaceuticals annual total current assets?
- What is the all time high annual current assets for Citius Pharmaceuticals?
- What is Citius Pharmaceuticals annual current assets year-on-year change?
- What is Citius Pharmaceuticals quarterly total current assets?
- What is the all time high quarterly current assets for Citius Pharmaceuticals?
- What is Citius Pharmaceuticals quarterly current assets year-on-year change?
What is Citius Pharmaceuticals annual total current assets?
The current annual current assets of CTXR is $14.22 M
What is the all time high annual current assets for Citius Pharmaceuticals?
Citius Pharmaceuticals all-time high annual total current assets is $72.81 M
What is Citius Pharmaceuticals annual current assets year-on-year change?
Over the past year, CTXR annual total current assets has changed by -$20.15 M (-58.63%)
What is Citius Pharmaceuticals quarterly total current assets?
The current quarterly current assets of CTXR is $14.22 M
What is the all time high quarterly current assets for Citius Pharmaceuticals?
Citius Pharmaceuticals all-time high quarterly total current assets is $116.94 M
What is Citius Pharmaceuticals quarterly current assets year-on-year change?
Over the past year, CTXR quarterly total current assets has changed by -$13.79 M (-49.22%)